SMTL ID : 6a3n.2 (1 other biounit)

Crystal structure of the PDE9 catalytic domain in complex with inhibitor 2

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.60 Å
Oligo State
homo-dimer
Ligands
2 x ZN: ZINC ION(Non-covalent)
2 x MG: MAGNESIUM ION(Non-covalent)
2 x 9Q9: 1-cyclopentyl-6-({(2R)-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxopropan-2-yl}amino)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Wu, Y. et al., Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia. J. Med. Chem. (2019)
Release Date
2019-04-10
Peptides
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A

Toggle Identical (AB)

Related Entries With Identical Sequence

6a3n.1 | 6lzz.1